Clinical Trial Update: Intraperitoneal LSTA1 in CRS-HIPEC [Phase 1]

View source ↗

Summary

The document reports the withdrawal of a Phase 1 trial of intraperitoneal LSTA1 for peritoneal cancers. The conditions include colorectal cancer, ovarian cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer
• Ovarian Cancer
• Peritoneal Metastasis

Drugs mentioned

• LSTA1

Snippet

Sponsor: University of California, San Diego | Conditions: Colorectal Cancer, Ovarian Carcinoma | Phase 1 | Status: WITHDRAWN